Cargando…
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
In the past few years, there has been increasing focus on the use of messenger RNA (mRNA) as a new therapeutic modality. Current clinical efforts encompassing mRNA-based drugs are directed toward infectious disease vaccines, cancer immunotherapies, therapeutic protein replacement therapies, and trea...
Autores principales: | Wadhwa, Abishek, Aljabbari, Anas, Lokras, Abhijeet, Foged, Camilla, Thakur, Aneesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076378/ https://www.ncbi.nlm.nih.gov/pubmed/32013049 http://dx.doi.org/10.3390/pharmaceutics12020102 |
Ejemplares similares
-
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021) -
Nanoparticles for mucosal vaccine delivery
por: Thakur, Aneesh, et al.
Publicado: (2020) -
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
por: Xu, You, et al.
Publicado: (2021) -
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
por: Yuan, Yuan, et al.
Publicado: (2023) -
Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)